Haemonetics Corporation (HAE)

Haemonetics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 27, 2025	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021
Net Income	175.44	167.68	117.56	115.4	43.38	79.47
Depreciation & Amortization	112.61	115.59	97.22	93.31	97.75	84.29
Stock-Based Compensation	31.64	29.64	28.33	25.58	24.36	25.52
Other Adjustments	15.77	-29.21	13.35	13.26	21.96	-20.79
Change in Receivables	17.69	6.96	-24.19	-24.42	-34.97	44.12
Changes in Inventories	38.54	-64.7	-60.06	30.75	24.31	-38.91
Changes in Accounts Payable	-19.29	-19.21	44.58	39.82	7.64	-56.42
Changes in Income Taxes Payable	4.22	0.23	-0.98	1.69	2.87	-3.82
Changes in Other Operating Activities	-19.04	-25.23	-34.05	-22.33	-15.02	-4.65
Operating Cash Flow	338.84	181.73	181.75	273.06	172.26	108.81
Operating Cash Flow Growth	162.16%	-0.01%	-33.44%	58.51%	58.32%	-31.23%
Capital Expenditures	-30.76	-39.28	-38.13	-191.33	-96.51	-37.04
Sale of Property, Plant & Equipment	3.3	23.25	1.81	1.61	2.02	1.82
Payments for Business Acquisitions	-	-150.91	-243.85	-2.85	-2.5	-434.8
Proceeds from Business Divestments	-	43.29	1.5	0.85	10.64	44.59
Other Investing Activities	-90.72	-38.26	-43.72	47.93	51.8	9.29
Investing Cash Flow	-74.89	-161.9	-322.39	-143.79	-86.35	-425.44
Short-Term Debt Issued	-	-	-	-	-	-60
Net Short-Term Debt Issued (Repaid)	-	-	-	-	-	-60
Long-Term Debt Issued	-	950	110	330	-	500
Long-Term Debt Repaid	-6.25	-502.69	-72.25	-339.63	-17.5	-21.88
Net Long-Term Debt Issued (Repaid)	-6.25	447.31	37.75	-9.63	-17.5	478.13
Issuance of Common Stock	9.51	8.33	7.21	7.02	6.55	10.23
Repurchase of Common Stock	-192.68	-235.24	-5.89	-75	-	-
Net Common Stock Issued (Repurchased)	-183.17	-226.91	1.33	-67.98	6.55	10.23
Other Financing Activities	-0.12	-111.58	-0.92	-22.76	-4.8	-60.9
Financing Cash Flow	-228.41	108.82	38.16	-100.36	-15.75	367.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents	6.99	-0.69	-3.19	-3.94	-2.98	4.18
Net Cash Flow	42.52	127.96	-105.67	24.97	67.19	54.99
Free Cash Flow	308.08	142.45	143.63	81.73	75.75	71.77
Free Cash Flow Growth	116.27%	-0.82%	75.73%	7.89%	5.56%	-34.44%
FCF Margin	23.37%	10.47%	10.97%	6.99%	7.63%	8.24%
Free Cash Flow Per Share	6.40	2.81	2.79	1.59	1.48	1.40
Levered Free Cash Flow	255.46	582.38	163.89	57.68	46.91	441.04
Unlevered Free Cash Flow	280.19	142.77	136.22	79.24	76.08	41.26

Updated Feb 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q